Status:
COMPLETED
Effect of Ile-Pro-Pro (IPP) on Endothelial Function in Patients With Coronary Artery Disease
Lead Sponsor:
Boston University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
21-80 years
Phase:
NA
Brief Summary
This study will investigate whether the lacto-tripeptide Ile-Pro-Pro (IPP) improves the function of the endothelium in patients with coronary artery disease. The study has a crossover design. Particip...
Eligibility Criteria
Inclusion
- Coronary artery disease
Exclusion
- Treatment with an ACE inhibitor or ARB
- Pregnancy
- Other major illness
- Treatment with an investigational drug within 4 weeks
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT00924157
Start Date
July 1 2009
End Date
May 1 2012
Last Update
May 25 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston University Medical Center
Boston, Massachusetts, United States, 02118